Ignite Creation Date:
2025-12-24 @ 5:30 PM
Ignite Modification Date:
2026-01-24 @ 11:42 PM
Study NCT ID:
NCT02064868
Status:
TERMINATED
Last Update Posted:
2019-03-22
First Post:
2014-02-14
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Effect of Serelaxin Versus Standard of Care in Acute Heart Failure (AHF) Patients
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-01-31
Start Date Type:
ACTUAL
Primary Completion Date:
2017-03-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-04-25
Completion Date Type:
ACTUAL
First Submit Date:
2014-02-14
First Submit QC Date:
None
Study First Post Date:
2014-02-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-04-24
Results First Submit QC Date:
None
Results First Post Date:
2019-03-22
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-12-18
Last Update Post Date:
2019-03-22
Last Update Post Date Type:
ACTUAL